Epoch Investment Partners Inc. Has $16.31 Million Holdings in Encompass Health Corporation $EHC

Epoch Investment Partners Inc. lessened its position in Encompass Health Corporation (NYSE:EHC) by 78.0% during the 1st quarter, HoldingsChannel.com reports. The fund owned 168,627 shares of the company’s stock after selling 598,601 shares during the period. Epoch Investment Partners Inc.’s holdings in Encompass Health were worth $16,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its position in shares of Encompass Health by 24.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock valued at $510,047,000 after purchasing an additional 948,202 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Encompass Health by 21.7% during the 4th quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock worth $359,271,000 after purchasing an additional 603,472 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in Encompass Health by 27.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,722,887 shares of the company’s stock valued at $289,008,000 after purchasing an additional 581,812 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in Encompass Health by 6.8% during the 2nd quarter. Alliancebernstein L.P. now owns 2,039,314 shares of the company’s stock valued at $250,081,000 after purchasing an additional 129,276 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is currently owned by insiders.

Encompass Health Stock Performance

Encompass Health stock opened at $112.66 on Friday. The firm has a market capitalization of $11.18 billion, a P/E ratio of 18.81, a P/E/G ratio of 2.46 and a beta of 0.74. The stock has a fifty day moving average price of $104.97 and a two-hundred day moving average price of $103.80. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter in the previous year, the company posted $1.37 earnings per share. Encompass Health’s quarterly revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, analysts anticipate that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.21 dividend. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Wall Street Analyst Weigh In

Several research analysts have commented on EHC shares. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. TD Cowen began coverage on shares of Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 price objective on the stock. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research report on Friday, May 22nd. Barclays cut their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Finally, Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $143.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.